Generic drugmakers denied bid for bifurcated trial in Humana's US price-fixing case
MLex Summary: Major US generic drug manufacturers failed to convince a Pennsylvania federal judge overseeing a bellwether price-fixing trial over claims from Humana to bifurcate the proceedings into liability and damages...To view the full article, register now.
Already a subscriber? Click here to view full article